Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation HC Tseng, K Kanayama, K Kaur, SH Park, S Park, A Kozlowska, S Sun, ... Oncotarget 6 (24), 20002, 2015 | 105 | 2015 |
Augmented IFN-γ and TNF-α induced by probiotic bacteria in NK cells mediate differentiation of stem-like tumors leading to inhibition of tumor growth and reduction in … VT Bui, HC Tseng, A Kozlowska, PO Maung, K Kaur, P Topchyan, ... Frontiers in immunology 6, 576, 2015 | 97 | 2015 |
Novel strategy to expand super-charged NK cells with significant potential to lyse and differentiate cancer stem cells: differences in NK expansion and function between healthy … K Kaur, J Cook, SH Park, P Topchyan, A Kozlowska, N Ohanian, C Fang, ... Frontiers in immunology 8, 297, 2017 | 77 | 2017 |
Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs AK Kozlowska, P Topchyan, K Kaur, HC Tseng, A Teruel, T Hiraga, ... Journal of Cancer 8 (4), 537, 2017 | 76 | 2017 |
Natural killer cells: diverse functions in tumor immunity and defects in pre-neoplastic and neoplastic stages of tumorigenesis A Jewett, J Kos, K Kaur, T Safaei, C Sutanto, W Chen, P Wong, ... Molecular Therapy-Oncolytics 16, 41-52, 2020 | 72 | 2020 |
NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis A Jewett, J Kos, Y Fong, MW Ko, T Safaei, MP Nanut, K Kaur Seminars in cancer biology 53, 178-188, 2018 | 70 | 2018 |
Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation … K Kaur, P Topchyan, AK Kozlowska, N Ohanian, J Chiang, PO Maung, ... Oncoimmunology 7 (5), e1426518, 2018 | 69 | 2018 |
Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy K Kaur, MP Nanut, MW Ko, T Safaie, J Kos, A Jewett Current opinion in immunology 51, 170-180, 2018 | 67 | 2018 |
Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human … AK Kozlowska, HC Tseng, K Kaur, P Topchyan, A Inagaki, VT Bui, ... Cancer Immunology, Immunotherapy 65, 1085-1097, 2016 | 67 | 2016 |
Osteonecrosis of the jaw developed in mice: Disease variants regulated by γδ T cells in oral mucosal barrier immunity S Park, K Kanayama, K Kaur, HCH Tseng, S Banankhah, DT Quje, ... Journal of Biological Chemistry 290 (28), 17349-17366, 2015 | 57 | 2015 |
Probiotic-treated super-charged NK cells efficiently clear poorly differentiated pancreatic tumors in Hu-BLT mice K Kaur, AK Kozlowska, P Topchyan, MW Ko, N Ohanian, J Chiang, ... Cancers 12 (1), 63, 2019 | 51 | 2019 |
Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice AK Kozlowska, K Kaur, P Topchyan, A Jewett Cancer Immunology, Immunotherapy 65, 835-845, 2016 | 44 | 2016 |
Deficiencies in natural killer cell numbers, expansion, and function at the pre-neoplastic stage of pancreatic cancer by KRAS mutation in the pancreas of obese mice K Kaur, HH Chang, P Topchyan, JM Cook, A Barkhordarian, G Eibl, ... Frontiers in immunology 9, 1229, 2018 | 39 | 2018 |
Novel strategies to target cancer stem cells by NK cells; studies in humanized mice AK Kozlowska, K Kaur, P Topchyan, A Jewett Front Biosci (Landmark Ed) 22 (2), 370-84, 2017 | 34 | 2017 |
ADCC against MICA/B is mediated against differentiated oral and pancreatic and not stem-like/poorly differentiated tumors by the NK cells; loss in cancer patients due to down … K Kaur, T Safaie, MW Ko, Y Wang, A Jewett Cancers 13 (2), 239, 2021 | 33 | 2021 |
Differential cytotoxicity but augmented IFN-γ secretion by NK cells after interaction with monocytes from humans, and those from wild type and myeloid-specific COX-2 knockout mice HC Tseng, A Arasteh, K Kaur, A Kozlowska, P Topchyan, A Jewett Frontiers in immunology 6, 259, 2015 | 33 | 2015 |
Plasticity of myeloid cells during oral barrier wound healing and the development of bisphosphonate-related osteonecrosis of the jaw Y Sun, K Kaur, K Kanayama, K Morinaga, S Park, A Hokugo, A Kozlowska, ... Journal of Biological Chemistry 291 (39), 20602-20616, 2016 | 31 | 2016 |
Suppression of gingival NK cells in precancerous and cancerous stages of pancreatic cancer in KC and BLT-humanized mice K Kaur, HH Chang, J Cook, G Eibl, A Jewett Frontiers in immunology 8, 1606, 2017 | 30 | 2017 |
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells K Kaur, MW Ko, N Ohanian, J Cook, A Jewett Scientific Reports 10 (1), 20363, 2020 | 29 | 2020 |
Multiple defects of natural killer cells in cancer patients: anarchy, dysregulated systemic immunity, and immunosuppression in metastatic cancer A Jewett, J Kos, K Kaur, TL Turnsek, B Breznik, E Senjor, P Wong, ... Critical Reviews™ in Immunology 40 (2), 2020 | 26 | 2020 |